IsoRay (ISR) Announces First Human Prostate Implant Utilizing Cesium-131 Seeds
Tweet Send to a Friend
IsoRay Inc. (NYSE: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE